Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

J&J files rare blood disorder drug siltuximab in US and EU

Orphan drug to be assessed for use in the treatment of multicentric Castleman disease

Anthony Zook resigns as Vivus CEO

Replaced by former J&J executive Seth Fischer

- PMLiVE

Baxter taps Coherus for Enbrel biosimilar

Deal to develop copy of Amgen and Pfizer's arthritis and psoriasis is worth up to $246m

- PMLiVE

Salix wins rheumatology contract

Comms agency to produce Simple Tasks awareness campaign for British Society for Rheumatology

- PMLiVE

GSK splits media account between two agencies

GroupM and Omnicom are the winners in GSK’s latest consolidation

- PMLiVE

VIDEO interview: Neil Weir, UCB

Senior vice president of global research at UCB discusses the importance of patient-centricity and the value of collaboration

- PMLiVE

Sanofi plans its mobile diabetes future

Next phase of iBGStar project will focus on wider connectivity

China flag thumb

GSK blamed for employee bribes in China

Xinhua news agency claims company was complicit in the payment of kickbacks to doctors

- PMLiVE

Bayer wins new Eylea approval in Europe

Macular oedema indication will provide more competition for Novartis’ Lucentis

- PMLiVE

AZ’s olaparib enters phase III for ovarian cancer

Development of the drug had previously been halted in 2011

Novartis building

Novartis wins childhood arthritis indication for Ilaris in EU

EC gives green light to drug for the treatment of systemic juvenile idiopathic arthritis

- PMLiVE

Roche’s Torsten Hoffmann to join Zealand Pharma

Joins the Danish biotech as chief scientific officer

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links